Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity.
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.
Standing Data Disproves Biomechanical Mechanism for Balance-Based Torso-Weighting.
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
Autoimmunity in multiple sclerosis need not be abnormal.
Muscular dystrophy in a patient with multiple sclerosis. Another "double-trouble"?
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
Physical activity and pediatric multiple sclerosis: Developing a research agenda.
A case of relapsing-remitting tumour-like inflammation of the central nervous system.
The cerebellar channelopathy of multiple sclerosis.
Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion.
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System.
Diffusion MRI abnormalities detection with orientation distribution functions: A multiple sclerosis longitudinal study.
Microglia play a major role in direct viral-induced demyelination.
Pseudobulbar affect: prevalence and management.
Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment.
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases.
PML in a patient with lymphocytopenia treated with dimethyl fumarate.
Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: A case report and literature review.
Twenty years of experience on stem cell transplantation in iran.
Myeloid cell distribution and activity in multiple sclerosis.
Association of interleukin-1 gene cluster polymorphisms and haplotypes with multiple sclerosis in an Iranian population.
[Structural and functional changes of the hippocampus in patients with multiple sclerosis and their relationship with memory processes].
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.
Pages
« first
‹ previous
…
553
554
555
556
557
558
559
560
561
…
next ›
last »